COCAINE, CORTICOSTERONE AND EMOTIONAL BEHAVIOR

可卡因、皮质酮和情绪行为

基本信息

  • 批准号:
    2881762
  • 负责人:
  • 金额:
    $ 7.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-07-01 至 2002-06-30
  • 项目状态:
    已结题

项目摘要

Cocaine is one of the most potent reinforcers known; both humans and animals will crave and expend much energy to acquire these drugs. However, one of the many negative consequences of repeated cocaine use in humans is the development of panic and anxiety following cocaine withdrawal. Thus, cocaine has pleasurable, reinforcing properties, as well as anxiety-inducing effects. Although dopamine is known to be an important mediator of cocaine, stress hormones, such as corticosteroids, are thought to play a critical but paradoxical role in both the reinforcing and anxiety-inducing effects of cocaine. The goal of this proposal is to investigate the role of corticosteroids in the long-lasting anxiolytic (pleasurable) and anxiogenic properties of cocaine in rats. A paradigm that measures both long-lasting anxiolytic and anxiogenic effects of prior repeated cocaine administration by a single behavioral response, the acoustic startle reflex, will be described. Depending on the experience, both pleasurable and fearful states can be measured by the acoustic startle response. Startle decreases in an environment where the rats have previously been positively reinforced, and conversely, is increased following fear conditioning. The paradigm will be used to test the hypothesis that corticosteroids are critical for both the anxiolytic and anxiogenic effects of repeated cocaine following withdrawal. Adrenalecomized rats will be given repeated administration of cocaine, and then following a withdrawal period, will be tested for increased in pleasure and fear by measuring amplitude of the startle reflex. Corticosterone will also be given in an attempt to reverse the effects of adrenalectomy. In addition, pharmacological inhibition of corticosterone production will also be evaluated. The results will indicate whether corticosteroids are necessary for both the pleasurable and anxiety-inducing effects of cocaine, or for only one of the effects. The study will have important implications for understanding the environmental and behavioral control over the pleasurable and anxiogenic properties of cocaine and whether stress hormones regulate both of these properties or regulate cocaine-related pleasure and anxiety differentially. The outcome of the experiments should have ramifications for understanding drug abuse and relapse, and development of treatment and prevention strategies.
可卡因是已知的最有效的兴奋剂之一;人类和动物都会渴望并花费大量精力来获得这些药物。 然而,人类重复使用可卡因的许多负面后果之一是可卡因戒断后恐慌和焦虑的发展。 因此,可卡因具有令人愉快的,增强的特性,以及焦虑诱导作用。 虽然已知多巴胺是可卡因的重要介质,但应激激素(如皮质类固醇)被认为在可卡因的强化和焦虑诱导作用中起着关键但矛盾的作用。 本研究的目的是研究皮质类固醇在大鼠可卡因的持久抗焦虑(愉悦)和致焦虑特性中的作用。 一个范例,测量持久的抗焦虑和焦虑的影响,以前重复可卡因管理的一个单一的行为反应,声惊吓反射,将被描述。 根据不同的经验,愉快和恐惧的状态都可以通过声音惊吓反应来测量。 在老鼠先前被积极强化的环境中,惊吓减少,相反,在恐惧条件反射后增加。 该范例将用于检验皮质类固醇对戒断后重复可卡因的抗焦虑和致焦虑作用至关重要的假设。 将给予肾上腺皮质化的大鼠重复施用可卡因,然后在戒断期后,通过测量惊吓反射的幅度来测试快乐和恐惧的增加。还将给予皮质酮以试图逆转肾上腺切除术的影响。 此外,还将评价皮质酮产生的药理学抑制。结果将表明皮质类固醇是否是可卡因的愉悦和焦虑诱导作用所必需的,或者仅是其中一种作用。 这项研究将对理解可卡因的愉悦和焦虑特性的环境和行为控制以及压力激素是否调节这两种特性或差异调节可卡因相关的愉悦和焦虑具有重要意义。实验的结果应当对理解药物滥用和复吸以及制定治疗和预防战略产生影响。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Corticosterone facilitates retention of contextually conditioned fear and increases CRH mRNA expression in the amygdala.
皮质酮有助于保留情境条件恐惧并增加杏仁核中 CRH mRNA 的表达。
  • DOI:
    10.1016/s0166-4328(03)00216-x
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    2.7
  • 作者:
    Thompson,BarbaraL;Erickson,Kristine;Schulkin,Jay;Rosen,JeffreyB
  • 通讯作者:
    Rosen,JeffreyB
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JEFFREY B ROSEN其他文献

JEFFREY B ROSEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JEFFREY B ROSEN', 18)}}的其他基金

Mechanisms of Context Conditioning in the Developing Rat
发育中大鼠的环境条件作用机制
  • 批准号:
    8695916
  • 财政年份:
    2014
  • 资助金额:
    $ 7.5万
  • 项目类别:
Oxytocin's novel antianxiety effect
催产素的新颖抗焦虑作用
  • 批准号:
    8246092
  • 财政年份:
    2012
  • 资助金额:
    $ 7.5万
  • 项目类别:
THE ROLE OF THE AMYGDALA IN ACOUSTIC STARTLE
杏仁核在听觉惊吓中的作用
  • 批准号:
    3052822
  • 财政年份:
    1988
  • 资助金额:
    $ 7.5万
  • 项目类别:
THE ROLE OF THE AMYGDALA IN ACOUSTIC STARTLE
杏仁核在听觉惊吓中的作用
  • 批准号:
    3052821
  • 财政年份:
    1987
  • 资助金额:
    $ 7.5万
  • 项目类别:
UDEL Administrative Core
UDEL 行政核心
  • 批准号:
    8727228
  • 财政年份:
  • 资助金额:
    $ 7.5万
  • 项目类别:

相似海外基金

Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
  • 批准号:
    MR/X034690/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.5万
  • 项目类别:
    Fellowship
Clinitouch-360: A digital health platform enabling robust end-to-end care of patients in Primary Care with depression and anxiety
Clinitouch-360:数字健康平台,可为初级保健中的抑郁和焦虑患者提供强大的端到端护理
  • 批准号:
    10098274
  • 财政年份:
    2024
  • 资助金额:
    $ 7.5万
  • 项目类别:
    Collaborative R&D
Mental Health and Occupational Functioning in Nurses: An investigation of anxiety sensitivity and factors affecting future use of an mHealth intervention
护士的心理健康和职业功能:焦虑敏感性和影响未来使用移动健康干预措施的因素的调查
  • 批准号:
    10826673
  • 财政年份:
    2024
  • 资助金额:
    $ 7.5万
  • 项目类别:
Visual analysis system to detect and predict the signs of anxiety in healthcare
用于检测和预测医疗保健中焦虑迹象的视觉分析系统
  • 批准号:
    2902083
  • 财政年份:
    2024
  • 资助金额:
    $ 7.5万
  • 项目类别:
    Studentship
Using generative AI combined with immersive technology to treat anxiety disorders
利用生成式人工智能结合沉浸式技术治疗焦虑症
  • 批准号:
    10109165
  • 财政年份:
    2024
  • 资助金额:
    $ 7.5万
  • 项目类别:
    Launchpad
Healthy Young Minds: co-producing a nature-based intervention with rural High School students to promote mental well-being and reduce anxiety
健康的年轻心灵:与农村高中生共同开展基于自然的干预措施,以促进心理健康并减少焦虑
  • 批准号:
    MR/Z503599/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.5万
  • 项目类别:
    Research Grant
"Flashforward" imagery and anxiety in young adults: Risk mechanisms and intervention development
年轻人的“闪现”意象和焦虑:风险机制和干预措施的发展
  • 批准号:
    MR/Y009460/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.5万
  • 项目类别:
    Fellowship
How parents manage climate anxiety: coping and hoping for the whole family
父母如何应对气候焦虑:全家人的应对和希望
  • 批准号:
    DP230101928
  • 财政年份:
    2024
  • 资助金额:
    $ 7.5万
  • 项目类别:
    Discovery Projects
An innovative biofeedback enhanced adaptive extended reality (XR) device to reduce perinatal pain and anxiety during and after childbirth
一种创新的生物反馈增强型自适应扩展现实 (XR) 设备,可减少分娩期间和分娩后的围产期疼痛和焦虑
  • 批准号:
    10097862
  • 财政年份:
    2024
  • 资助金额:
    $ 7.5万
  • 项目类别:
    Collaborative R&D
Digital cognitive-behavior therapy for anxiety and depressive disorders: Building an impactful research project from international partnerships and knowledge exchange in primary care
针对焦虑和抑郁症的数字认知行为疗法:通过初级保健领域的国际合作和知识交流建立一个有影响力的研究项目
  • 批准号:
    480808
  • 财政年份:
    2023
  • 资助金额:
    $ 7.5万
  • 项目类别:
    Miscellaneous Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了